Melissa Landon — SPARQNOW

At-a-Glance

Head of Commercial and Business Development, AI + Automation at MilliporeSigma
Advisory Board Member at Sandboxaq
Former Chief Strategy Officer at Cyclica, which was acquired by Recursion
Specializes in go-to-market strategy and structuring partnerships for transformative technologies
Focuses on the intersection of AI, automation, and drug discovery

Biography

Melissa Landon is a scientist, strategist, and business executive dedicated to bringing transformative technologies to market. She currently leads commercialization for a venture within MilliporeSigma, focusing on the intersection of AI, automation, and drug discovery. In this role, she works with founders, executive teams, and investors to navigate key inflection points, shaping go-to-market strategies and structuring strategic partnerships to create value.